Disulfiram

This classification denotes a multidrug resistance modulator and angiogenesis inhibitor with the molecular formula C10H20N2S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TR3MLJ1UAI, chemically known as 1,1-dithiobis(n,n-diethylthioformamide) but generally known as disulfiram, which bears US NIH Compound Identifier 3117. European Medicines Agency schedules Disulfiram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06326MIG. The term DISULFIRAM is an International Non-Proprietary Name. World Health Organization schedules disulfiram in its Anatomical Therapeutic Chemical (ATC) Classification. DISULFIRAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule disulfiram under HS 29303000 and SITC 51543. As of Q4 2014, DISULFIRAM remains the US FDA Preferred Term for this commodity. Disulfiram bears US NLM identifiers UMLS ID C0012772 and NCI Concept Code C447. SMILES: CCN(CC)C(=S)SSC(=S)N(CC)CC.